Nemaura Medical Stock Shares Owned By Insiders
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
Nemaura Medical fundamentals help investors to digest information that contributes to Nemaura Medical's financial success or failures. It also enables traders to predict the movement of Nemaura Pink Sheet. The fundamental analysis module provides a way to measure Nemaura Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nemaura Medical pink sheet.
Nemaura |
Nemaura Medical Company Shares Owned By Insiders Analysis
Nemaura Medical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Nemaura Medical Shares Owned By Insiders | 48.30 % |
Most of Nemaura Medical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nemaura Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 48.3% of Nemaura Medical are shares owned by insiders. This is 218.18% higher than that of the Health Care Equipment & Supplies sector and 210.61% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Nemaura Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nemaura Medical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics of similar companies.Nemaura Medical is currently under evaluation in shares owned by insiders category among its peers.
Nemaura Fundamentals
| Return On Equity | -7.24 | ||||
| Return On Asset | -0.49 | ||||
| Current Valuation | 22.58 M | ||||
| Shares Outstanding | 28.9 M | ||||
| Shares Owned By Insiders | 48.30 % | ||||
| Shares Owned By Institutions | 7.70 % | ||||
| Number Of Shares Shorted | 52.57 K | ||||
| Price To Earning | (707.14) X | ||||
| Price To Book | 122.56 X | ||||
| Price To Sales | 804.62 X | ||||
| Revenue | 77.04 K | ||||
| Gross Profit | (1.48 M) | ||||
| EBITDA | (8.17 M) | ||||
| Net Income | (14.14 M) | ||||
| Cash And Equivalents | 14.75 M | ||||
| Cash Per Share | 0.61 X | ||||
| Total Debt | 20.03 M | ||||
| Current Ratio | 0.99 X | ||||
| Book Value Per Share | (0.55) X | ||||
| Cash Flow From Operations | (8.45 M) | ||||
| Short Ratio | 0.30 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 36 | ||||
| Beta | 0.046 | ||||
| Market Capitalization | 2.43 M | ||||
| Total Asset | 14.56 M | ||||
| Retained Earnings | (51.88 M) | ||||
| Working Capital | (8.73 M) | ||||
| Current Asset | 9.55 M | ||||
| Current Liabilities | 658.01 K | ||||
| Z Score | -7.48 | ||||
| Net Asset | 14.56 M |
About Nemaura Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nemaura Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nemaura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nemaura Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |